The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) awarded a total of 41 “innovation passports” for new drugs under development last year. The grant of a passport opens the door to the agency’s Innovative Licensing and Access Pathway (ILAP), which was introduced in January 2021.
In a 30 December update, the MHRA said it had received 71 applications for a passport during the first year...








